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A commentary on
Blood eosinophilia is associated with unfavorable hospitalization outcomes in children with 
bronchiolitis
by Shein SL, Li H, Gaston B. Pediatr Pulmonol (2016) 51(1):77–83. doi:10.1002/ppul.23219
The recently published article by Shein et  al. identified 1356 inpatients aged <24  months with 
bronchiolitis and studied the presence of eosinophils among those patients with a complete blood 
count. The cohort who were eosinophil-positive were found to have more prolonged hospitalization 
compared to the eosinophil-negative group, OR 1.88, p = 0.020. Interestingly, clinical severity as 
described by use of mechanical ventilation was also greater in this cohort (1).
Eosinophils and eosinophil degranulation products, such as eosinophil cationic protein (ECP), 
have been identified in a subset of patients with bronchiolitis (2). Bronchiolitis is most commonly 
caused by a viral infection of the lower respiratory tract by respiratory syncytial virus (RSV). Early 
responses to infection of the epithelium include a neutrophilic and mononuclear cellular infiltra-
tion of the lining of the bronchioles (3, 4). Some patients exhibit both peripheral and localized 
eosinophilia. Eosinophils have been identified in lung biopsies in severe RSV (5).
One peripheral biomarker that may be useful in the classification of cellular responses to RSV 
lower respiratory tract infection is ECP. The presence of elevated serum levels of ECP is also present 
in other obstructive lung diseases. In a study (CHOC/Stanford) of serum samples from cystic fibro-
sis (CF) patients and asthmatic and bronchiolitic patients, all demonstrated elevated serum levels 
compared to control. The CF group had the highest ECP serum levels compared to controls and 
non CF patients (p = 0.008). In this study, ECP did neither directly correlate with IgE nor absolute 
eosinophil counts (6).
This suggests that there may be a subset of patients with activation of eosinophils and normal 
eosinophil counts, who may experience deleterious symptoms as a result of the direct cellular injury 
caused by ECP. Future studies may be completed to further analyze this sub-population of patients.
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